As the fallout (and questions) of the official end to the tirzepatide shortage continues, news outle...
Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been ...
The South Florida Business Journal reported on the boom in compounded GLP-1s and Scott explained why...
The Hill ran Yet Another Article on how compounded versions of GLP-1 drugs are spreading — a boon fo...
Medscape wonders how Lilly’s making tirzepatide available in vials will affect the GLP-1 market. Eli...
In one of the many stories about compounded GLP-1s and the battle with pharma companies, Scott makes...
The Hill called compounding GLP1s a “loophole,” but otherwise wrote a decent piece explaining how te...
APC helped push back against the California Board of Pharmacy’s plan to all but outlaw glutathione, ...
The Washington Post’s story “Eli Lilly ramps up its fight against imitation weight-loss drugs” conta...
In its article on Lilly's introduction of DTC discounted vials of Zepbound, IHP included a great quo...